Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
doi:10.1016/j.arr.2016.08.006
Tirzepatide's dual receptor mechanism How tirzepatide works: Dual GIP/GLP-1 receptor agonist Single molecule, two pathways GIP (glucose-dependent insulinotropic polypeptide) + GLP-1 Weekly subcutaneous injection FDA approved for diabetes and obesity GIP pathway effects: Enhances insulin secretion Improves insulin sensitivity Promotes fat metabolism Reduces inflammation Works synergistically with GLP-1 GLP-1 pathway effects: Suppresses appetite (central brain effects) Slows gastric emptying (moderate) Increases satiety Reduces glucagon Improves glucose control Combined tirzepatide results: 15-22% average body weight loss (monotherapy) Superior to semaglutide (GLP-1 alone) Well-tolerated in trials Approved and available See our tirzepatide dosing guide , semaglutide vs tirzepatide , and peptides for weight loss at SeekPeptides
It stimulates collagen production, reduces inflammation, and promotes wound healing
These results demonstrated the additive benefits of targeting both amylin and GLP-1 pathways for glycemic control and weight management in type 2 diabetes and supported advancement to Phase 3 development
US$ 22.64
US$ 23.21
US$ 26.09
US$ 26.64
US$ 27.28
US$ 27.81
US$ 25.27
